drugset

drugset / Trial / NCT00865592

Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

NCT00865592 ↗

Phase 3 Terminated 450 enrolled Phenomix Forest Laboratories · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to demonstrate that dutogliptin/PHX1149T is safe and tolerable.

Timeline

Start: 2009-03
Primary completion: 2011-01
Completion: 2011-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dutogliptin	Small molecule	400 mg	—

Indications